No Data
No Data
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $125 to $150
Merck & Company (MRK) Gets a Hold From Morgan Stanley
Buy Rating on Merck & Co. Amid Temporary Setbacks and Strong Growth Outlook
Express News | Merck & Co Inc : BofA Global Research Cuts Price Objective to $145 From $150
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating
Pertussis Treatment Market Projected to Hit US$ 5.3 Billion by 2034, With a 3.4% CAGR | Fact.MR Report